Kaito Harada
About
Kaito Harada is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Kaito Harada has authored 46 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 18 papers in Oncology and 17 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kaito Harada's work include Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (21 papers) and Acute Lymphoblastic Leukemia research (17 papers). Kaito Harada is often cited by papers focused on Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (21 papers) and Acute Lymphoblastic Leukemia research (17 papers). Kaito Harada collaborates with scholars based in Japan and United States. Kaito Harada's co-authors include Yoshiko Atsuta, Takahiro Fukuda, Makoto Onizuka, Naoyuki Uchida, Shingo Yano, Yuho Najima, Masamitsu Yanada, Noriko Doki, Tatsuo Ichinohe and Shuichi Ota and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.
In The Last Decade
Kaito Harada
43 papers receiving 251 citations
Peers
Kaito Harada
Roberta Demichelis‐Gómez Mexico
Jeff Schriber United States
N. Maillard France
Christophe Peczynski France
Emmanouil Nikolousis United Kingdom
Maria Åström Sweden
Yalçın Kímya Türkiye
E Nagura Japan
MG Valsecchi Italy
Richard J. Buka United Kingdom
Citations per year, relative to Kaito Harada Kaito Harada (= 1×)
peers
Roberta Demichelis‐Gómez
Countries citing papers authored by Kaito Harada
Since
Specialization
Citations
This map shows the geographic impact of Kaito Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaito Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaito Harada more than expected).
Fields of papers citing papers by Kaito Harada
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kaito Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaito Harada. The network helps show where Kaito Harada may publish in the future.
Co-authorship network of co-authors of Kaito Harada
This figure shows the co-authorship network connecting the top 25 collaborators of Kaito Harada. A scholar is included among the top collaborators of Kaito Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaito Harada. Kaito Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Harada, Kaito, Junya Kanda, Masahiro Hirayama, et al.. (2024). Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease. Transplantation and Cellular Therapy. 31(2). 103.e1–103.e13.
2.
Mizuno, Shohei, Akiyoshi Takami, Koji Kawamura, et al.. (2024). Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion. SHILAP Revista de lepidopterología. 5(2). 369–378.
3.
Harada, Kaito. (2023). Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation. International Journal of Hematology. 118(2). 158–168.
4.
Onizuka, Makoto, Eri Kikkawa, Shinichiro Machida, et al.. (2023). Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia. PubMed. 6(3). 80–86.
5.
Jo, Tomoyasu, Yasuyuki Arai, Tadakazu Kondo, et al.. (2023). Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach. British Journal of Haematology. 202(2). 356–368.
6.
Harada, Kaito, Junya Kanda, Masahiro Hirayama, et al.. (2023). Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease. Blood. 142(Supplement 1). 4905–4905.
7.
Najima, Yuho, Takayoshi Tachibana, Kaito Harada, et al.. (2023). A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation. Blood. 142(Supplement 1). 3606–3606.
8.
Harada, Kaito, Makoto Onizuka, Ryujiro Hara, et al.. (2022). Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection. Journal of Infection and Chemotherapy. 28(9). 1279–1285.
9.
Arai, Yasuyuki, Tadakazu Kondo, Kaito Harada, et al.. (2022). Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI. Hematological Oncology. 40(5). 1041–1055.
10.
Harada, Kaito, Takahiro Fukuda, Yukiyasu Ozawa, et al.. (2022). Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Cytotherapy. 24(9). 954–961.
11.
Harada, Kaito, Shohei Mizuno, Shingo Yano, et al.. (2022). Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia. Annals of Hematology. 101(3). 643–653.
12.
Hara, Ryujiro, Makoto Onizuka, Eri Kikkawa, et al.. (2021). Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of Hematology. 100(10). 2479–2486.
13.
Hara, Ryujiro, Hiroshi Kawada, Yara Yukie Kikuti, et al.. (2021). A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor. International Journal of Hematology. 113(4). 606–610.
14.
Harada, Kaito, Takashi Yahata, Makoto Onizuka, et al.. (2021). Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration in the adipocyte-rich bone marrow microenvironment. Biochemical and Biophysical Research Communications. 557. 180–186.
15.
Kaito, Satoshi, Yuho Najima, Kaito Harada, et al.. (2020). Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype. Bone Marrow Transplantation. 55(7). 1337–1346.
16.
Hara, Ryujiro, Makoto Onizuka, Kaito Harada, et al.. (2020). The Role of Hypertension and Renin-angiotensin-aldosterone System Inhibitors in Bleomycin-induced Lung Injury. Clinical Lymphoma Myeloma & Leukemia. 21(4). e321–e327.
17.
Tachibana, Takayoshi, Yuho Najima, Yu Akahoshi, et al.. (2020). The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. Annals of Hematology. 99(10). 2393–2404.
18.
Harada, Kaito, Shigeo Fuji, Junya Kanda, et al.. (2020). Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(9). 1784–1795.
19.
Onizuka, Makoto, Jun Amaki, Shinichiro Machida, et al.. (2019). Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide. PubMed. 2(1). 1–4.
20.
Konishi, Tatsuya, Noriko Doki, Yuta Yamada, et al.. (2019). Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia. Annals of Hematology. 99(1). 147–155.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Roberta Demichelis‐Gómez Breakdown of academic impact, for papers by Jeff Schriber Breakdown of academic impact, for papers by N. Maillard Breakdown of academic impact, for papers by Christophe Peczynski Breakdown of academic impact, for papers by Emmanouil Nikolousis Breakdown of academic impact, for papers by Maria Åström Breakdown of academic impact, for papers by Yalçın Kímya Breakdown of academic impact, for papers by E Nagura Breakdown of academic impact, for papers by MG Valsecchi Breakdown of academic impact, for papers by Richard J. Buka